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ABSTRACT 
The NF-B signaling cascade relays external signals essential for B-cell growth and survival. 
This cascade is frequently hijacked by cancers that arise from the malignant transformation of 
germinal center (GC) B cells, underscoring the importance of deciphering the function of NF-B 
in these cells. The NF-B signaling cascade is comprised of two branches, the canonical and 
alternative NF-B pathways, mediated by distinct transcription factors. The expression and 
function of the transcription factors of the alternative pathway, RELB and NF-B2, in late B-cell 
development is incompletely understood. Using conditional deletion of relb and nfkb2 in GC B 
cells, we here report that ablation of both RELB and NF-B2, but not of the single transcription 
factors, resulted in the collapse of established GCs. RELB/NF-B2 deficiency in GC B cells was 
associated with impaired cell cycle entry and reduced expression of the cell-surface receptor 
ICOSL that promotes optimal interactions between B and T cells. Analysis of human tonsillar 
tissue revealed that plasma cells and their precursors in the GC expressed high levels of NF-
B2 relative to surrounding lymphocytes. In accordance, deletion of nfkb2 in murine GC B cells 
resulted in a dramatic reduction of antigen-specific antibody-secreting cells, while deletion of 
relb had no effect. These results demonstrate that the transcription factors of the alternative NF-
B pathway control distinct stages of late B-cell development, which may have implications for 
B-cell malignancies that aberrantly activate this pathway.         
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SIGNIFICANCE 
In many human B-cell cancers, a complex signaling cascade called nuclear factor-B (NF-B) is 
abnormally activated by genetic mutations. The uncontrolled activity of NF-B due to genetic 
mutations promotes the formation B-cell tumors. The NF-B cascade is comprised of two 
distinct pathways. We here define the role of one of these routes, called the alternative NF-B 
pathway, in the normal cells from which these B-cell tumors are derived, namely germinal center 
B cells or plasma cells. We found that the inactivation of the alternative NF-B pathway led to 
the loss of germinal center B cells and impaired plasma cell development. Understanding the 
role of this pathway in normal cells may provide important insights into how aberrant activation 
promotes B-cell tumors. 
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INTRODUCTION 
During T-cell-dependent immune responses, B cells diversify their antigen-receptors by somatic 
hypermutation (SHM) of the immunoglobulin variable region (IgV) genes (1). SHM and selection 
of B cells with increased antigen-affinity occurs within GCs. The efficiency of the GC reaction is 
enhanced by topological and temporal segregation of proliferation and SHM within the dark 
zone (DZ) and antigen-selection within the light zone (LZ) (2-4). Recirculation of GC B cells 
between these zones result in the generation of high-affinity, often isotype-switched memory B 
cells and plasma cells (PCs) (2-5). The GC reaction is critical for immunity; however, errors 
during SHM and class-switch recombination can lead to genetic aberrations that promote 
lymphomagenesis (6, 7). Recently, genetic mutations resulting in constitutive activation of the 
NF-B signaling cascade were identified in a large fraction of GC-derived B-cell lymphomas and 
multiple myeloma (MM) (8-16). 
Activation of NF-B signaling results in the transcription of NF-B target genes that 
regulate many cellular processes including cell survival and proliferation (17, 18). The NF-B-
signaling cascade comprises two branches, the canonical and alternative (or noncanonical) NF-
B pathways, which activate specific NF-B transcription factor subunits that occur mainly as 
heterodimers. Canonical NF-B pathway activation leads to the nuclear translocation of c-REL, 
RELA and p50, while alternative pathway activation causes nuclear translocation of RELB and 
p52. In normal cells, NF-B activation is transient and tightly controlled. Conversely, constitutive 
NF-B activation due to genetic alterations in NF-B pathway components is pathogenic (8, 9). 
Mutations affecting multiple different NF-B signaling components have been identified in 
several GC-derived B-cell malignancies which can lead to the constitutive activation of the 
canonical and/or alternative NF-B pathways (8-16). The selection of these mutations implies 
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that NF-B-signaling may have an important biological role during normal GC B-cell 
development that is “hijacked” in tumors (7, 8).  
Distinguishing the functions of the canonical and alternative NF-B pathways by 
studying upstream regulators may be complicated by the possibility of pathway crosstalk. 
Therefore, focusing on the downstream transcription factor subunits may help to clarify the 
specific roles of the separate NF-B pathways. Towards this aim, early work on human 
lymphoid tissue revealed that nuclear translocation of canonical NF-B subunits within GCs 
occurred only within a subset of cells in the LZ (19). By ablating the canonical NF-B 
transcription factors c-REL or RELA specifically in GC B cells, we recently showed that c-REL 
was essential for GC maintenance, whereas RELA was required for PC development (20). The 
expression, activation status and function of the alternative NF-B transcription factors RELB 
and p52 in GC B cells remain largely unknown. Due to the diverse functions of the alternative 
NF-B pathway in a range of cell types, mice with constitutional knockout of either relb or nfkb2 
(the gene encoding the p100/p52 precursor, referred to as NF-B2, from which p52 is generated 
upon activation) have severe defects in lymphoid organization (21-23), thus hampering the 
analysis of GC B-cell development in these mice. We here determined the expression pattern of 
the alternative NF-B subunits in human lymphoid tissue and investigated their roles during GC 
B-cell development in vivo by crossing conditional relb and/or nfkb2 alleles to mice that express 
Cre-recombinase in GC B-cells. We found that RELB and NF-B2 were jointly required to 
maintain the GC B-cell reaction while the development of antigen-specific PCs was impaired 
upon deletion of only nfkb2 in GC B-cells. 
 
RESULTS 
 
Expression and activation of alternative NF-B subunits in human GC B cells. The 
expression and activation of the alternative NF-B subunits in GC B cells has not been 
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investigated. Since CD40-stimulation strongly activates both NF-B pathways (24, 25), the 
CD40-CD40L interaction occurring between LZ B cells and T-follicular helper cells (Tfh cells) is 
expected to activate alternative NF-B signaling. Indeed, Western-blot analysis of human 
tonsillar GC B cells cultured on CD40L-expressing fibroblasts demonstrated p100→p52 
processing (Fig. 1A, left) and thus alternative pathway activation. This was accompanied by the 
downregulation of the GC master regulator BCL6, an event believed to occur during LZ 
selection (7), and resulted in nuclear translocation of p52 along with the canonical subunit p50 
(Fig. 1A, right). In accordance with the in vitro findings, nuclear translocation of p52 could be 
observed in vivo in tonsillar GCs within LZ B cells by immunofluorescence (IF) analysis (Fig. 
1B). Thus, nuclear translocation of p52 was detected within a small subset of LZ B cells and 
therefore suggests that the alternative NF-B pathway may have a functional role in LZ B cells. 
 Interestingly, we observed strong staining of p100/p52 in PCs localizing in the tonsillar 
subepithelium that were identified by staining for the major PC regulator BLIMP1 (26, 27), 
relative to lymphocytes at the border of the subepithelium (Fig. 1C, top). The same staining 
pattern was observed in BLIMP1+ PC precursors in the LZ of tonsillar GCs (Fig. 1C, bottom). 
These observations may point towards a potential role of the alternative NF-B pathway in the 
development of normal PCs and their precursors in the GC. The large amount of NF-B2 in the 
cytoplasm may predispose BLIMP1+ plasma cell precursors and plasma cells to undergo strong 
signaling via the alternative NF-B pathway upon stimulation. Alternative pathway activation 
was observed via strong p100→p52 processing in two MM cell lines (Fig. 1D), and to a lesser 
extent in a cell line corresponding to diffuse large B-cell lymphoma (DLBCL), where mutations 
leading to activation of the alternative pathway have been observed in a subset of cell lines and 
primary cases (13, 15). Of note, Western-blot analysis revealed that the canonical NF-B 
subunit c-REL was expressed at dramatically lower levels in the MM lines compared to the 
DLBCL lines (Fig. 1D). A low expression of c-REL relative to surrounding lymphocytes appears 
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to also be a feature of normal PC precursors in the LZ (Fig. 1E, right), as identified by strong 
staining for IRF4 which at high expression levels promotes PC differentiation along with BLIMP1 
(27, 28). In contrast, cytoplasmic p100/p52 expression is increased in several IRF4+ cells (Fig. 
1E, left), similar to the corresponding BLIMP1 staining (Fig. 1c, bottom). Collectively, these data 
suggest that relative to mature B cells, PCs and their precursors in the GC are characterized by 
a distinct expression pattern of NF-B subunits; high expression of NF-B2 and low expression 
of c-REL.  
 
Combined GC B cell-specific deletion of relb and nfkb2 impairs the GC reaction. To 
determine the in vivo role of RELB and NF-B2 during GC B-cell development, we crossed 
conditional relb and nfkb2 alleles (29) to Cγ1-Cre mice (30), either alone or in combination, to 
delete the genes in GC B cells. Expression of Cγ1-Cre is induced upon T cell-dependent 
immunization, resulting in the Cre-mediated deletion of loxP-flanked genes in the majority of GC 
B cells (30). relbfl/flCγ1-Cre, nfkb2fl/flCγ1-Cre or relbfl/flnfkb2fl/flCγ1-Cre mice and the 
corresponding heterozygous and Cγ1-Cre control mice were immunized with sheep red blood 
cells (SRBCs) to induce a robust GC response. 14d following immunization, the fractions of 
splenic CD95hiPNAhi GC B cells in relbfl/flCγ1-Cre and nfkb2fl/flCγ1-Cre were not significantly 
different from those in the controls (Fig. 2A, left&middle). In contrast, the fraction of splenic GC 
B cells in relbfl/flnfkb2fl/flCγ1-Cre mice was markedly reduced in comparison to relbfl/+nfkb2fl/+Cγ1-
Cre and Cγ1-Cre mice 14d post-immunization (Fig. 2A, right). In accordance, 
immunohistochemistry (IHC) revealed reduced BCL6+ GCs within B-cell follicles in 
relbfl/flnfkb2fl/flCγ1-Cre mice compared to controls at d14 post-immunization (Fig. 2B). Together, 
these findings demonstrate that single ablation of either RELB or NF-B2 in GC B cells had no 
significant impact on the GC reaction. Instead, combined ablation of RELB and NF-B2 in GC B 
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cells strongly impaired the GC reaction, demonstrating that both subunits of the alternative NF-
B pathway are required for GC maintenance. 
To define the temporal kinetics of the impaired GC reaction observed in 
relbfl/flnfkb2fl/flCγ1-Cre mice, we determined the fractions of splenic GC B cells at various time-
points following immunization with SRBCs. 7d post-immunization, the fraction of GC B cells in 
relbfl/flnfkb2fl/flCγ1-Cre mice was comparable to that observed in the controls (SI Appendix, Fig. 
S1A). Since the conditional relb and nfkb2 alleles were constructed such that Cre-mediated 
recombination of loxP-sites is accompanied by expression of an enhanced-GFP (eGFP) (29), it 
was possible to trace the gene-deleted GC B cells by flow cytometry for eGFP expression. 
Analysis for eGFP expression in GC B cells from relbfl/flnfkb2fl/flCγ1-Cre and relbfl/+nfkb2fl/+Cγ1-
Cre mice revealed single peaks of expression (SI Appendix, Fig. S1A, bottom right), indicating 
that the vast majority of GC B cells have deleted the relb and nfkb2 alleles at d7. GC B-cell 
development therefore occurred normally in relbfl/flnfkb2fl/flCγ1-Cre mice up to d7 of the GC 
reaction, after which GC B cells were progressively lost.  
 To investigate the possibility of a selective loss of a particular GC B-cell subpopulation, 
we determined the fractions of CXCR4hiCD86lo DZ and CXCR4loCD86hi LZ B-cell fractions (31) 
over time (SI Appendix, Fig. S1B). Statistically significant differences in the DZ and LZ B-cell 
fractions between relbfl/flnfkb2fl/flCγ1-Cre and Cγ1-Cre control mice were observed; however, 
these differences were minor and do not point towards a preferential loss of a specific GC B-cell 
subpopulation. Thus, these data suggest that RELB and NF-B2 are required for the 
maintenance of both DZ and LZ subpopulations past d7 of the GC reaction. 
 
Identification of genes controlled by the alternative NF-B subunits RELB and NF-B2 in 
GC B cells. To identify the biological programs controlled by RELB and NF-B2 that are 
required for GC maintenance, we isolated GC B cells from relbfl/flnfkb2fl/flCγ1-Cre and Cγ1-Cre 
9 
 
control mice 7d post-immunization and conducted an RNA-seq analysis. We reasoned that 
gene expression changes that ultimately contribute to the loss of relb/nfkb2-deleted GC B cells 
at later time-points would already be detectable in these cells at d7. Splenic eGFP+ GC B cells 
were flow cytometrically sorted from two relbfl/flnfkb2fl/flCγ1-Cre mice, and GC B cells were 
isolated from three Cγ1-Cre mice 7d post-immunization with SRBCs, and subjected to RNA-seq 
analysis. Reduced transcript counts of the relb and nfkb2 genes were identified in GC B cells 
from relbfl/flnfkb2fl/flCγ1-Cre compared to Cγ1-Cre mice (SI Appendix, Fig. S2A), and the 
relbfl/flnfkb2fl/flCγ1-Cre and Cγ1-Cre samples clustered into two separate groups in an 
unsupervised analysis (SI Appendix, Fig. S2B). Since a monoclonal antibody was available for 
the surface molecule CD36, a putative fatty acid translocase (32), we could confirm reduced 
protein expression of CD36 on eGFP+ GC B cells from relbfl/flnfkb2fl/flCγ1-Cre mice in 
comparison to GC B cells from Cγ1-Cre mice and eGFP+ GC B cells from relbfl/+nfkb2fl/+Cγ1-Cre 
mice (Fig. 3A). Together, these observations validate the robustness of the RNA-seq data set.  
 Differentially expressed sequence analysis (DESeq) of RELB/NF-B2-proficient vs. 
RELB/NF-B2-deficient GC B cells identified 59 transcripts with greater than 2.5-fold reduced 
expression and 84 transcripts with greater than 2.5-fold increased expression in the relb/nfkb2-
deleted B cells at a significance threshold of p<0.01 (for the identity of the corresponding genes, 
fold-change and p values, see Datasets 1&2). Transcripts with reduced expression could be 
assigned to functional categories, with genes involved in the immune response and metabolism 
representing the largest categories (SI Appendix, Fig. S2C; for the identity of the genes, see 
Dataset 1). The metabolism category was largely comprised of two groups of genes with 
presumptive roles in either protein or lipid metabolism.  
We next used gene set enrichment analysis (GSEA) (33) to further investigate the gene 
expression changes among the genotypes. The largest group of signatures enriched in the 
control cells vs. RELB/NF-B2-deficient cells was associated with cell cycle regulation (Fig. 3B 
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and Dataset 3), suggesting that RELB/NF-B2 may control genes involved in proliferation. To 
test this possibility, we cultured RELB/NF-B2-deficient B cells purified from relbfl/fl nfbk2fl/flCD19-
Cre mice and control B cells isolated from CD19-Cre mice with CD40 and IL-4, a combination 
that provides a strong proliferative signal and activates the alternative pathway via CD40. By 
analyzing the proliferation profile of these cells at d3 of stimulation, we found that a significantly 
smaller fraction of eGFP+RELB/NF-B2-deficient B cells entered the cell cycle in comparison to 
control B cells (Fig. 3C). Of note, the relb/nfkb2-deleted B cells that were able to enter the cell 
cycle appeared to proliferate slightly more than controls. Together, the data suggest that 
RELB/NF-B2-deficient B-cells have a reduced ability to enter the cell cycle, which may 
contribute to the loss of RELB/NF-B2-deficient GC B cells over time that we observed in vivo.  
To investigate whether RELB/NF-B2-deficient GC B cells proliferate less than WT GC 
B cells in vivo, we assessed BrdU incorporation at day 10. At day 10, a reduction in relb/nfkb2-
deleted vs. WT GC B cells is already evident (SI Appendix, Fig. S3A). We chose this time-point 
for analysis since it is in-between day 7 (when relb/nfkb2-deleted GC B cells are present at 
normal frequencies; SI Appendix, Fig. S1A) and day 14 (when relb/nfkb2-deleted GC B cells are 
greatly reduced; Fig. 2). We observed a trend towards decreased BrdU-incorporation in 
relb/nfkb2-deleted vs. WT GC B cells identified as CD19+GL7hi cells (SI Appendix, Fig. S3C, for 
gating strategy see SI Appendix, Fig. S3B). We believe these differences are minor since the 
percentage of GFP+ cells is variable between different mice (SI Appendix, Fig. S3D), which 
could reflect counterselection against relb/nfkb2-deleted GC B cells. Since the BrdU protocol 
involves fixation, we were unable to specifically measure BrdU incorporation in GFP+ GC B 
cells, which could dilute the actual difference in the fraction of cells that have incorporated BrdU. 
The second largest group of signatures identified in the GSEA analysis was associated 
with the metabolism of proteins (Fig. 3B). In addition, when we compared our RNA-seq data set 
to a library of normal and pathological lymphoid gene expression signatures (34), five signatures 
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were found to be enriched in RELB/NF-B2-proficient vs. deficient GC B cells (SI Appendix, Fig. 
S4), including a ribosomal protein signature and two X box-binding protein-1 (XBP1)-associated 
gene expression signatures. XBP-1 is required for the unfolded protein response and is 
essential for the development of PCs capable of secreting large amounts of antibodies (26, 27). 
This suggests that in GC B cells, the alternative NF-B subunits may be required to set up a 
program that allows for the efficient production of proteins and facilitates antibody secretion, 
presumably in GC B cells destined to become plasmablasts (see below).         
Finally, we have previously shown that deletion of the gene encoding the canonical NF-
B subunit c-REL (rel) in GC B cells leads to the involution of GCs (20) similar to what we 
observed upon relb/nfkb2 deletion, suggesting that c-REL and the alternative NF-B subunits 
exert non-redundant functions during the GC reaction. In support of this notion, genes with 
reduced expression in relb/nfkb2 or rel-deleted GC B cells vs. controls were found to be largely 
mutually exclusive (Fig. 3D), indicating that the different canonical and alternative NF-B 
subunits control distinct transcriptional programs within the same GC context. 
 
RELB/NF-B2-deficient GC B cells have reduced cell-surface expression of ICOSL. The 
interaction between inducible T-cell co-stimulator (ICOS), expressed on Tfh cells, and ICOS 
ligand (ICOSL), expressed on GC B cells, promotes the selection of high-affinity B cells (35). 
The expression of ICOSL is regulated by the alternative NF-B subunits in response to B-cell 
activating factor (BAFF) receptor (BAFF-R)-stimulation (36) and also CD40-stimulation (29) in 
murine B cells. To determine the extent to which the deletion of relb and nfkb2 in GC B cells 
affects ICOSL expression on GC B cells in vivo, we stained splenic mononuclear cells from 
relbfl/flnfkb2fl/flCγ1-Cre and Cγ1-Cre control mice for ICOSL and GC markers 10d following 
SRBC immunization. eGFP+RELB/NF-B2-deficient GC B-cells from relbfl/flnfkb2fl/flCγ1-Cre mice 
showed a slight but significant reduction in the surface expression of ICOSL compared to WT 
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GC B-cells and eGFP–RELB/NF-B2-proficient GC B cells from the same mice (Fig. 3E; SI 
Appendix, Fig. S2D). Reduced cell-surface expression of ICOSL on RELB/NF-B2-deficient GC 
B cells may impair optimal GC B cell–Tfh cell interactions within the GC, which may contribute 
to their gradual disappearance after d7 of the GC reaction. 
 
Deletion of nfkb2 in GC B cells impairs the development of antigen-specific PCs. The 
combined deletion of relb and nfkb2 resulted in the involution of established GCs and, as 
expected, PCs in relbfl/flnfkb2fl/flCγ1-Cre mice were also reduced compared to relbfl/+nfkb2fl/+Cγ1-
Cre and Cγ1-Cre mice (SI Appendix, Fig. S5). The deletion of relb or nfkb2 alone in GC B cells 
did not however affect GC B-cell maintenance upon SRBC immunization (Fig. 2A) or 
immunization with 4-hydroxy-3-nitrophenyl-acetyl coupled to keyhole limpet hemocyanin (NP-
KLH) (SI Appendix, Fig. S6). Therefore, to determine whether RELB or NF-B2 are required for 
the generation of antigen-specific PCs in the GC reaction in vivo, we immunized relbfl/flCγ1-Cre 
or nfkb2fl/flCγ1-Cre and the corresponding control mice with NP-KLH and performed ELISA and 
ELISPOT analysis. 28 days post-immunization, we found that whereas deletion of relb in GC B 
cells did not significantly reduce NP-specific IgG1 serum levels or the number of NP-specific 
IgG1 antibody-secreting cells (ASCs) in the spleen and bone marrow (Fig. 4A), GC-specific 
deletion of nfkb2 led to a ~3-fold reduction in NP-specific IgG1 serum levels and an 8-10-fold 
reduction in ASCs compared to the control mice (Fig. 4B). This defect does not appear to be 
due to the loss of plasma cells, as we were able to detect eGFP+, and therefore nfkb2-deleted, 
CD138+ plasma cells (see SI Appendix, Fig. S7&8). While the basis for this observation remains 
to be determined, these results provide functional evidence for a biological role of NF-B2, 
which is highly expressed in PCs and their precursors, in the development of PCs that cannot 
be complemented by other NF-B subunits.   
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DISCUSSION 
In agreement with previous work using bone-marrow chimeras (21, 23), we found that GC B-cell 
development proceeds normally in mice with GC B cell-specific ablation of either RELB or NF-
B2 alone. In contrast, combined ablation of RELB and NF-B2 resulted in the progressive loss 
of GC B cells. Therefore, RELB and NF-B2 are jointly required for the maintenance of the GC 
reaction. 
Among the alternative NF-B subunits, only RELB is a transcriptional activator. It was 
therefore perhaps surprising to observe that ablation of RELB alone did not impair the GC 
reaction, revealing redundancy between RELB and NF-B2 in GC B cells. This redundancy in 
the absence of either subunit may be explained by dimerization of the remaining transcription 
factor with subunits of the canonical NF-B pathway (37). It is clear, however, that redundancy 
does not exist between the canonical and alternative NF-B pathways, since the GC 
maintenance defect observed in the combined absence of RELB and NF-B2 was not 
compensated for by canonical NF-B subunits.  
Evidence suggests that CD40-stimulation by Tfh cells leads to activation of both the 
canonical and alternative NF-B pathways in LZ B cells. An additional signal that may activate 
the alternative pathway in LZ B cells is stimulation by BAFF (38). Recent work provides 
evidence that Tfh cells secrete BAFF locally to adjacent LZ B cells (39). Of note, while 
abolishing BAFF secretion by Tfh cells impaired the selection of high-affinity GC B cells, it had 
no impact on the maintenance of the GC reaction. This finding suggests that the inability of LZ B 
cells to transmit signals through the BAFF-R is unlikely to contribute to the loss of GCs 
observed upon GC B cell-specific deletion of relb and nfkb2. Since follicular dendritic cells may 
contribute to BAFF production in the GC (40), the conclusive determination of the function of 
BAFF signaling during the GC reaction would therefore require conditional deletion of the BAFF-
R in GC B cells. 
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GCs are believed to reach maturity at ~d7 of the GC reaction, the time-point at which 
DZ/LZ polarization has been established and when selection of high-affinity GC B-cell mutants, 
followed by cyclic reentry, is initiated (2, 3). It is clear that continuous or periodic signals are 
required for the maintenance of mature GCs, as the involution of established GCs has been 
observed upon inhibition of CD40-signaling (41). Via specific conditional gene deletion within 
GC B cells it has been shown that c-MYC, c-REL and NF-B-induced kinase (NIK), an upstream 
regulator of the alternative NF-B pathway that can also activate the canonical pathway (42, 
43), are all required for the maintenance of established GCs (20, 44-47). We here demonstrated 
that RELB and NF-B2 have a similarly critical role in this process. 
It is becoming increasingly clear that individual NF-B subunits have divergent roles in 
GC and post-GC development. In the case of the canonical subunits, RELA is dispensable for 
the GC reaction but promotes PC development, whereas c-REL is required for GC maintenance 
(20) similar to what we demonstrated here for the alternative NF-B subunits RELB and NF-
B2. Interestingly, however, gene expression profiling analysis revealed that the genes 
controlled by c-REL and RELB/NF-B2 are largely distinct. This finding suggests that the 
respective transcription factors regulate complementary biological programs that are 
independently required for the GC reaction to persist over time. Impaired cell proliferation and 
reduced cell-surface expression of ICOSL on LZ B cells may contribute to the progressive loss 
of RELB/NF-B2-deficient GC B cells. LZ B cells undergoing selection receive signals from Tfh 
cells that promote their survival and license cyclic reentry and division in the DZ. Our results 
suggest that LZ B cells lacking the alternative subunits may respond improperly to these 
signals, resulting in fewer cells reentering the cell cycle and seeding the GC over time. In 
addition, reduced cell-surface expression of ICOSL could lead to suboptimal interactions with 
Tfh cells, further depriving these cells of critical signals necessary for GC maintenance. 
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Several observations suggest a biological role for the alternative NF-B pathway in PCs. 
Our finding of strong protein expression of the NF-B2 subunit in tonsillar PCs is in accordance 
with a gene expression profile analysis that reported an upregulation of mRNA encoding NF-
B2 and RELB in human tonsillar and bone marrow PCs relative to other B-cell subsets (48). 
Moreover, murine plasmacytoma lines were characterized by the nuclear translocation of 
RELB/p52 (49). These observations are supported by the in vivo data reported here 
demonstrating a requirement for NF-B2 in PC development. The results of our GSEA analysis 
on RELB/NF-B2-deficient GC B cells raise the intriguing possibility that the alternative NF-B 
pathway may have a role in establishing a genetic program that facilitates the production of high 
amounts of antibodies in GC B cells destined to develop into PCs.           
 
 
 
MATERIAL AND METHODS 
 
Mice. The conditional relb and nfkb2 alleles, Cγ1-Cre and CD19-cre mice have been described 
(29, 30, 50). Mice were housed and treated in compliance with the guidelines of Columbia 
University. The animal protocol was approved by the institution’s IACUC. Mice were immunized 
with SRBCs or NP-KLH in complete Freund’s adjuvant as described (20). 
 
Cell culture. Discarded leftovers from routine tonsillectomies performed on children at 
Columbia-Presbyterian Medical Center were obtained. IRB approval was obtained for all 
procedures. Consent was not required since all patient identifiers were deidentified and 
specimens anonymized before use. Human GC B cells were isolated as described (51). Human 
GC B-cells and the CD40L expressing mouse feeder cell lines (52) were cultured in RPMI/10% 
FBS. P3HR1, SUDHL2 and JJN3 lines were cultured in Iscove’s-Modified Dulbecco’s Medium 
(IMDM)/10% FBS. U266 was cultured in IMDM/20% FBS, LY10 in IMDM with 15% human 
16 
 
serum (New York Blood Center). Murine B cells were purified and cultured with CD40 and/or IL-
4 as described (20). 
 
Immunoblot analysis. Cell lines or human GC B cells were subjected to immunoblot analysis 
as described (20).  For antibodies used, see Table S1. 
 
Flow cytometry. Spleen cell suspensions were stained and analyzed as described (20). For 
antibodies used, see Table S1. The CellTrace Violet Proliferation Kit (Thermo Fisher) was used 
for cell trace experiments. For the analysis of BrdU incorporation in GC B cells in vivo, mice 
were injected with 2 mg of BrdU and sacrificed 6h later. Staining for BrdU was conducted using 
the APC-BrdU kit (Becton Dickinson).  
Histology and immunohistochemistry. Spleen-sections (4m) were H&E-stained for 
morphological evaluation.  Immunohistochemical staining analysis was performed as described 
(20). For antibodies used, see Table S1. 
 
Immunofluorescence. For single-cell staining, cells were spun onto slides using a 
cytocentrifuge and fixed in 10% formalin for 20m followed by 20m of methanol fixation. Nuclear 
permeabilization was achieved via incubation with 0.2% triton/PBS. Cytospin slides were 
incubated with primary antibodies overnight followed by incubation with a Cy3-conjugated 
antibody. Slides were counterstained with DAPI (Molecular Probes). Images were acquired with 
an Eclipse E400 microscope (Nikon). Tissue sections were prepared and stained as described 
(51). For antibodies used, see Table S1. 
Gene expression analysis. B cells were isolated from spleens of relbfl/flnfkb2fl/flCγ1-Cre and 
Cγ1-Cre mice as described (20). eGFP+CD95hiPNAhi GC B cells were flow-cytometrically sorted 
from splenic B-cells of relbfl/flnfkb2fl/flCγ1-Cre mice and GC B cells were sorted from splenic B 
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cells of Cγ1-Cre mice. Total RNA was isolated using the Nucleospin RNA XS-isolation kit 
(Macherey-Nagel). NY Genome Center amplified RNA using the NuGEN Ovation RNA-Seq 
System V2 prior to RNA-sequencing. 35-40 million 2x50 bp paired-end reads were sequenced 
per sample on an HiSeq2500 (Illumina). DESeq analysis identified differentially expressed 
genes. Genes identified via RNA-seq analysis with reduced expression in RELB/NF-B2-
deficient GC B cells (Dataset 1) and genes identified via DNA microarray analysis with reduced 
expression in c-REL-deficient GC B cells (20) were compared after filtering out genes identified 
via the RNA-seq analysis that were not represented on the microarray. The overlap between the 
data sets was determined using Venny 2.1.0 available at 
http://bioinfogp.cnb.csic.es/tools/venny/index.html. GSEA (33) was used to identify signatures 
enriched in control vs. relb/nfkb2-deleted GC B cells. We screened the collection of signatures 
under the category CP:REACTOME, CP:KEGG, CP:BIOCARTA, BP:GO, MF:GO, CC:GO and 
signatures from a library of normal and pathological lymphoid gene expression signatures (34) 
to determine significant enrichment (FDR<25%, P≤ 0.05). 
ELISA and ELISPOT. ELISA and ELISPOT-analysis for NP-specific IgG1 or NP-specific IgG1 
antibody-secreting cells, respectively, was conducted as described (20). 
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FIGURE LEGENDS 
Figure 1. Expression and activation of alternative NF-B subunits in normal and 
transformed human GC B cells and PCs. (A) Human tonsillar GC B cells ex vivo or following 
24h of co-culture on CD40L expressing feeders were subjected to Western blot analysis for 
p100/p52 and BCL6 (left) and IF analysis for p105/p50 and p100/p52 (right, red) and DAPI 
(blue). (B) IF analysis of tonsil sections for p100/p52 and DAPI or CD20 in the GC light zone 
(LZ). (B) IF analysis of tonsil sections for p100/p52, BLIMP1 and DAPI in the subepithelium and 
GC LZ. (D) Western-blot analysis of DLBCL and MM cell lines for p100/p52, RELB, c-REL, 
RELA and p105/p50. (E) IF analysis of tonsil sections for IRF4 and NF-B subunits (either 
p100/p52 or c-REL) in the GC LZ. 
Figure 2. Combined GC B cell-specific deletion of relb and nfkb2 impairs the GC reaction. 
(A) relbfl/flCγ1-Cre, nfkb2fl/flCγ1-Cre or relbfl/flnfkb2fl/flCγ1-Cre mice and the corresponding 
heterozygous and Cγ1-Cre control mice were analyzed by flow cytometry 14d following 
immunization with SRBCs for CD95hiPNAhi splenic GC B cells. Summary of the frequencies of 
GC B cells (bottom).  Each symbol represents a mouse. Statistical significance was determined 
by Student’s t test (*, P<0.05; **, P<0.01). Data are shown as mean ± standard deviation (SD). 
(B) Spleen sections from the indicated genotypes were analyzed for the expression of BCL6 
and IgM via IHC. 
Figure 3. Identification of genes controlled by the alternative NF-B subunits RELB and 
NF-B2 in GC B cells. (A) relbfl/flnfkb2fl/flCγ1-Cre mice and the corresponding heterozygous and 
Cγ1-Cre control mice were analyzed via flow cytometry 8-12d following immunization with 
SRBCs for the expression of CD36 on CD95hiCD38lo GC B cells. Summary of the corresponding 
median fluorescence intensities (MFI) (bottom). (B) GSEA was used to identify gene signatures 
that were enriched in GC B cells from Cγ1-Cre vs. relbfl/flnfkb2fl/flCγ1-Cre mice. (Top) 
Representative example of a cell-cycle regulation signature. (Bottom) Gene sets showing 
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significant enrichment were grouped into functional categories. For the identity of the gene sets, 
see Dataset 3. (C) CellTrace Violet dilution in CD40+IL-4-stimulated B cells of the indicated 
genotypes (d3). (Top) Representative examples. Gates on the right identify non-dividing cells, 
gates on the left cells that have undergone divisions. (Bottom) Summary of the results. (D) Venn 
diagram showing the overlap of genes with reduced expression in RELB/NF-B2 or c-REL-
deficient GC B cells vs. controls. (E) relbfl/flnfkb2fl/flCγ1-Cre mice and Cγ1-Cre control mice were 
analyzed via flow cytometry 10d following immunization with SRBCs for the expression of 
ICOSL on CD95hiCD38lo GC B cells. Summary of the corresponding MFI in GC B cells from 
Cγ1-Cre mice and eGFP+ and eGFP– GC B cells from relbfl/flnfkb2fl/flCγ1-Cre mice (right). (A, C, 
E) Each symbol represents a mouse. Statistical significance was determined by Student’s t test 
(*, P<0.05; **, P<0.01). Data are shown as mean ± SD. 
Figure 4. Deletion of nfkb2 in GC B cells impairs the development of antigen-specific 
PCs. (A) relbfl/flCγ1-Cre and (B) nfkb2fl/flCγ1-Cre and the corresponding heterozygous and Cγ1-
Cre control mice were analyzed for NP9-specific IgG1 levels via ELISA (top left) and NP25-
specific IgG1 ASCs via ELISPOT (bottom) 28d following immunization with NP-KLH. Summary 
of the frequencies of NP25-specific IgG1 ASCs (right). Each symbol represents a mouse. 
Statistical significance was determined by Student’s t test (*, P<0.05; ***, P<0.001). Data are 
shown as mean ± SD.  
